Germany· DE-A57-8c2f73b47640427b
Hyalan
A medicinal product containing sodium hyaluronate, registered in Germany by Pharma Stulln Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Sodium Hyaluronate
- Manufacturer
- Pharma Stulln Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sodium hyaluronate in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAactive HA 0.1% eye dropsTriOn Pharma Ltd
- FinlandArtzalOrifarm Oy
- PolandHyalganInPharm Sp. z o.o.
- SwitzerlandIalugen, cremaIBSA Institut Biochimique SA
- United StatesSHINE pH CLEANSINGCH BIO CO., LTD.
- CanadaHY-50DECHRA LTD
- CzechiaHYALGANFidia Farmaceutici S.p.A., Abano Terme (PD)
- SwedenHyalgan 10 mg/ml Injektionsvätska, lösningEbb Medical AB
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Hyalgan
- Belgium · Hyalgan
- Bulgaria · Хиалган, Хилора
- Cyprus · Arthryal, Hyalgan
- Czechia · Hyalgan
- Spain · Hyalgan
- France · Hyalgan
- Greece · Arthryal, Gonilert
- Hungary · Conheal, Hyalgan
- Italy · Collirio Alfa Occhio Secco, Connettivina
- Luxembourg · Hyalgan
- Poland · Hyalgan
- Portugal · Hyalart
- Romania · Hyalgan
- Slovakia · Hyalgan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b5377c1e-75a5-40d1-92e2-7ffc411ded55 GET /v1/drugs/b5377c1e-75a5-40d1-92e2-7ffc411ded55?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Ocular Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Sodium Hyaluronate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about sodium hyaluronate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.